NEW YORK (GenomeWeb) – The Institute for Global Food Security, MBio Diagnostics, and Scienion today announced they will combine their technologies to create tools to monitor marine toxins.

IGFS is using Scienion's technology to manufacture portable immunoassay cartridges, and Chris Elliott's group at IGFS is currently using SciFlexarrayer technology to produce arrays in cartridges for the multiplexed detection of marine toxins using MBio's portable SnapEsi assay platform. IGFS is using the SciFlexarrayer technology to spot key reagents to run competitive immunoassays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.